Starpharma’s Antibiotic-Free BV Gel Launched In The UK
Australian sexual health specialist Starpharma launches its innovative, antibiotic-free Viva Gel BV bacterial vaginosis treatment in the UK.
You may also be interested in...
Scynexis highlights enrollment exceeding expectations in Phase III VVC trials; Daré prepares to enter Phase III to treat BV.
Starpharma has received approval for its innovative VivaGel condom in Japan, which will be launched in the first half of 2019 by Okamoto Industries.
A significant proportion of COVID-19 headache sufferers go on to develop “new daily persistent headaches” syndrome. German neurologists warn that these people are at danger of medication overuse headaches, as well as kidney damage, as a result of taking OTC analgesics on a daily basis.